Mo
Non vérifié

MoonLake Immunotherapeutics AG

Ce que nous écrivons

Annonces ÉconomiquesBiotechnologiePublicité/Marketing/Médias/Communication
02/02/2026
Biotechnologie
Annonces Économiques
Publicité/Marketing/Médias/Communication
MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day
1.00
08/01/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Annonces Économiques
MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day
1.00
05/11/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Annonces Économiques
MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering
1.00
28/09/2025
Biotechnologie
Annonces Économiques
Publicité/Marketing/Médias/Communication
MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab
1.00
05/08/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Annonces Économiques
MoonLake Immunotherapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
1.00
12/05/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Annonces Économiques
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update
1.00
25/04/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Annonces Économiques
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0